Death and dysfunction of transplanted β-cells: Lessons learned from type 2 diabetes?

Diabetes

Volumn 63, Issue 1, 2014, Pages 12-19

  Potter, Kathryn J ^a,b   Westwell Roper, Clara Y ^a,b   Klimek Abercrombie, Agnieszka M ^a,b   Warnock, Garth L ^a   Verchere, C Bruce ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GLUCOSE; PROINSULIN;

CELL DEATH; ENDOPLASMIC RETICULUM STRESS; HUMAN; INFLAMMATION; INSULIN RELEASE; MASS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 84891763331     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0364     Document Type: Review

References (62)

1. Warnock GL, Thompson DM, Meloche RM, et al. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation 2008;86: 1762-1766
2. Alejandro R, Barton FB, Hering BJ, Wease S; Collaborative Islet Transplant Registry Investigators. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008;86:1783-1788
3. Kahn SE, Zraika S, Utzschneider KM, Hull RL. The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality. Diabetologia 2009;52:1003-1012
4. Pørksen N, Grøfte T, Greisen J, et al. Human insulin release processes measured by intraportal sampling. Am J Physiol Endocrinol Metab 2002; 282:E695-E702
5. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110
6. Jonas JC, Bensellam M, Duprez J, Elouil H, Guiot Y, Pascal SM. Glucose regulation of islet stress responses and beta-cell failure in type 2 diabetes. Diabetes Obes Metab 2009;11(Suppl. 4):65-81
7. Westwell-Roper C, Dai DL, Soukhatcheva G, et al. IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 2011;187: 2755-2765
8. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355:1318-1330
9. Huurman VA, Hilbrands R, Pinkse GG, et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008; 3:e2435
10. Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation. Transplantation 2009;88:1286-1293
11. Deng S, Markmann JF, Rickels M, et al. Islet alone versus islet after kidney transplantation: metabolic outcomes and islet graft survival. Transplantation 2009;88:820-825
12. Koulmanda M, Smith RN, Qipo A, Weir G, Auchincloss H, Strom TB. Prolonged survival of allogeneic islets in cynomolgus monkeys after shortterm anti-CD154-based therapy: nonimmunologic graft failure? Am J Transplant 2006;6:687-696
13. Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation 2008;86:1799-1802
14. Webb MA, Illouz SC, Pollard CA, et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas 2008;37:282-287
15. Meier JJ, Hong-McAtee I, Galasso R, et al. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes 2006;55:2324-2332
16. Luzi L, Hering BJ, Socci C, et al. Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus. J Clin Invest 1996;97:2611-2618
17. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL. beta-Cell function following human islet transplantation for type 1 diabetes. Diabetes 2005;54:100-106
18. Täljedal IB, Shi CL, Rooth P. Functional aspects of mouse islets transplanted to the kidney. Diabetologia 1994;37(Suppl. 2):S112-S116
19. Shi CL, Täljedal IB. Dynamics of glucose-induced insulin release from mouse islets transplanted under the kidney capsule. Transplantation 1996; 62:1312-1318
20. Klimek AM, Soukhatcheva G, Thompson DM, et al. Impaired proinsulin processing is a characteristic of transplanted islets. Am J Transplant 2009; 9:2119-2125
21. Fiorina P, Vergani A, Petrelli A, et al. Metabolic and immunological features of the failing islet-transplanted patient. Diabetes Care 2008;31:436-438
22. Davalli AM, Perego L, Bertuzzi F, et al. Disproportionate hyperproinsulinemia, beta-cell restricted prohormone convertase 2 deficiency, and cell cycle inhibitors expression by human islets transplanted into athymic nude mice: insights into nonimmune-mediated mechanisms of delayed islet graft failure. Cell Transplant 2008;17:1323-1336
23. Davalli AM, Maffi P, Socci C, et al. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab 2000;85:3847-3852
24. Rickels MR, Mueller R, Teff KL, Naji A. beta-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. J Clin Endocrinol Metab 2010;95:1238-1246
25. Rickels MR, Naji A. Proinsulin processing and transplanted islets. Am J Transplant 2010;10:1495
26. Johnson JD, Ao Z, Ao P, et al. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant 2009;18:833-845
27. Pisania A, Weir GC, O'Neil JJ, et al. Quantitative analysis of cell composition and purity of human pancreatic islet preparations. Lab Invest 2010; 90:1661-1675
28. Ogawa Y, Noma Y, Davalli AM, et al. Loss of glucose-induced insulin secretion and GLUT2 expression in transplanted beta-cells. Diabetes 1995; 44:75-79
29. Meier JJ, Breuer TG, Bonadonna RC, et al. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 2012;55:1346-1354
30. Medarova Z, Moore A. MRI as a tool to monitor islet transplantation. Nat Rev Endocrinol 2009;5:444-452
31. Herynek V, Berková Z, Dovolilová E, et al. Improved detection of pancreatic islets in vivo using double contrast. Contrast Media Mol Imaging 2011;6: 308-313
32. Saudek F, Jirák D, Girman P, et al. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation 2010; 90:1602-1606
33. Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002;51:66-72
34. Jansson L, Eizirik DL, Pipeleers DG, Borg LA, Hellerström C, Andersson A. Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice. J Clin Invest 1995;96:721-726
35. Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007;56:2356-2370
36. Westermark GT, Westermark P, Nordin A, Törnelius E, Andersson A. Formation of amyloid in human pancreatic islets transplanted to the liver and spleen of nude mice. Ups J Med Sci 2003;108:193-203
37. Potter KJ, Abedini A, Marek P, et al. Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci USA 2010;107:4305-4310
38. Udayasankar J, Kodama K, Hull RL, et al. Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets. Diabetologia 2009;52:145-153
39. Westermark GT, Westermark P, Berne C, Korsgren O; Nordic Network for Clinical Islet Transplantation. Widespread amyloid deposition in transplanted human pancreatic islets. N Engl J Med 2008;359:977-979
40. Potter KJ, Scrocchi LA, Warnock GL, et al Amyloid inhibitors enhance survival of cultured human islets. Biochim Biophys Acta 2009;1790:566-574
41. Marzban L, Tomas A, Becker TC, et al. Small interfering RNA-mediated suppression of proislet amyloid polypeptide expression inhibits islet amyloid formation and enhances survival of human islets in culture. Diabetes 2008;57:3045-3055
42. Cardozo AK, Proost P, Gysemans C, Chen MC, Mathieu C, Eizirik DL. IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia 2003;46:255-266
43. Masters SL, Dunne A, Subramanian SL, et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1b in type 2 diabetes. Nat Immunol 2010;11:897-904
44. Huang X, Moore DJ, Ketchum RJ, et al. Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev 2008;29:603-630
45. Mohseni Salehi Monfared SS, Larijani B, Abdollahi M. Islet transplantation and antioxidant management: a comprehensive review. World J Gastroenterol 2009;15:1153-1161
46. Negi S, Park SH, Jetha A, Aikin R, Tremblay M, Paraskevas S. Evidence of endoplasmic reticulum stress mediating cell death in transplanted human islets. Cell Transplant 2012;21:889-900
47. Rodríguez-Mulero S, Montanya E. Islet graft response to transplantation injury includes upregulation of protective as well as apoptotic genes. Cell Transplant 2008;17:1025-1034
48. Kennedy J, Katsuta H, Jung MH, et al. Protective unfolded protein response in human pancreatic beta cells transplanted into mice. PLoS ONE 2010;5: e11211
49. Richards OC, Raines SM, Attie AD. The role of blood vessels, endothelial cells, and vascular pericytes in insulin secretion and peripheral insulin action. Endocr Rev 2010;31:343-363
50. Lau J, Mattsson G, Carlsson C, et al. Implantation site-dependent dysfunction of transplanted pancreatic islets. Diabetes 2007;56:1544-1550
51. Ris F, Toso C, Veith FU, Majno P, Morel P, Oberholzer J. Are criteria for islet and pancreas donors sufficiently different to minimize competition? Am J Transplant 2004;4:763-766
52. Whittington KB, Solomon SS, Lu ZN, Selawry HP. Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine. Endocrinology 1991;128:2671-2677
53. Ghofaili KA, Fung M, Ao Z, et al. Effect of exenatide on beta cell function after islet transplantation in type 1 diabetes. Transplantation 2007;83:24-28
54. Nomikos I, Kalogerakos K, Athanasiou E, et al. Role of hyperglycemia in isogeneic islet transplantation: an experimental animal study [published correction appears in Exp Clin Endocrinol Diabetes 2008;116:560.] Exp Clin Endocrinol Diabetes 2008;116:558-560
55. Björklund A, Bondo Hansen J, Falkmer S, Grill V. Openers of ATPdependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes. Diabetologia 2004;47:885-891
56. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005;54:2060-2069
57. Nagai T, Yasunami Y, Nagata N, Ryu S, Ono J, Ikeda S. Amelioration of hyperglycemia in streptozotocin-induced diabetic rats receiving a marginal mass of islet grafts by troglitazone, an oral antidiabetic agent. Pancreas 1996;13:381-387
58. Donath MY, Dalmas E, Sauter NS, Böni-Schnetzler M. Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab 2013;17:860-872
59. Larsen CM, Faulenbach M, Vaag A, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 2007;356:1517-1526
60. McCall M, Pawlick R, Kin T, Shapiro AM. Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice. Am J Transplant 2012;12:322-329
61. Matsumoto S, Takita M, Chaussabel D, et al. Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1b and TNF-α. Cell Transplant 2011;20:1641-1647
62. Brunham LR, Kruit JK, Pape TD, et al. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med 2007;13:340-347